
Kidney Diseases
Kidney diseases encompass a wide range of disorders that impair the normal function of the kidneys, organs vital for filtering waste products, balancing fluids and electrolytes, and regulating blood pressure. Kidney diseases can be acute or chronic, and if left untreated, can lead to end-stage renal disease (ESRD) requiring dialysis or kidney transplantation.
Chronic kidney disease (CKD) is a major public health concern, affecting about 10% of the global population. It progresses silently over time and is often associated with other chronic conditions like diabetes, hypertension, and cardiovascular disease. Early diagnosis and comprehensive management are key to slowing progression and preventing complications.
Types of Kidney Diseases
- Chronic Kidney Disease (CKD): Gradual loss of kidney function over time, often due to diabetes or hypertension.
- Acute Kidney Injury (AKI): Sudden loss of kidney function due to trauma, dehydration, infection, or medications.
- Glomerulonephritis: Inflammation of the glomeruli, the tiny filtering units of the kidney.
- Polycystic Kidney Disease (PKD): Genetic disorder characterized by fluid-filled cysts in the kidneys.
- Urinary Tract Infections (UTIs): Infections affecting the kidneys can lead to acute or chronic problems.
- Kidney Stones: Hard deposits of minerals and salts that can block urinary flow and cause damage.
- Nephrotic Syndrome: Characterized by heavy protein loss in urine due to glomerular damage.
- End-Stage Renal Disease (ESRD): The final stage of CKD requiring renal replacement therapy.
Causes and Risk Factors
The most common causes of kidney disease include:
- Diabetes mellitus: High blood glucose damages kidney vessels over time.
- Hypertension: High blood pressure stresses and damages kidney filters.
- Autoimmune disorders: Such as lupus and IgA nephropathy.
- Genetic conditions: Like polycystic kidney disease.
- Infections and toxins: Chronic infections or exposure to nephrotoxic drugs.
- Obstruction: Due to kidney stones, tumors, or prostate issues.
Pathophysiology
Kidney diseases impair the nephron’s ability to filter blood efficiently, leading to:
- Accumulation of waste products like urea and creatinine
- Imbalance in electrolytes (e.g., potassium, sodium, calcium)
- Retention of excess fluid, causing swelling and hypertension
- Hormonal imbalances affecting erythropoietin (anemia) and vitamin D metabolism
Over time, irreversible damage can lead to fibrosis, loss of nephron function, and the need for dialysis.
Symptoms
In early stages, kidney disease is often asymptomatic. As it progresses, symptoms may include:
- Fatigue and weakness
- Swelling in legs, ankles, or face (edema)
- Nausea and vomiting
- Loss of appetite
- Foamy urine or blood in urine
- Decreased urine output or frequency
- High blood pressure
- Shortness of breath
Advanced CKD may lead to complications such as anemia, bone disease, cardiovascular issues, and metabolic acidosis.
Diagnosis
Diagnosis is based on clinical evaluation, laboratory tests, and imaging:
Blood tests:
- Serum creatinine and blood urea nitrogen (BUN)
- Glomerular filtration rate (GFR) estimation
Urine tests:
- Proteinuria (albumin-to-creatinine ratio)
- Hematuria and urine sediment analysis
Imaging:
- Renal ultrasound or CT scan to detect structural abnormalities
Kidney biopsy: To confirm specific types of glomerular or interstitial disease
Staging of CKD
CKD is classified into five stages based on GFR:
- Stage 1: GFR ≥90 (normal function with some signs of damage)
- Stage 2: GFR 60–89
- Stage 3: GFR 30–59 (moderate damage)
- Stage 4: GFR 15–29 (severe damage)
- Stage 5: GFR <15 (kidney failure or ESRD)
Conventional Treatment
Management depends on the type, cause, and stage of kidney disease:
Blood pressure control:
- ACE inhibitors or ARBs to reduce proteinuria and slow progression
Blood sugar management: Tight control in diabetic patients
Dietary management:
- Low sodium, low protein, and potassium/phosphorus restrictions
Anemia treatment:
- Erythropoiesis-stimulating agents and iron supplementation
Bone mineral management:
- Vitamin D analogs, phosphate binders
Dialysis:
- Hemodialysis or peritoneal dialysis in ESRD
Kidney transplantation: Preferred treatment for eligible ESRD patients
Stem Cell Therapy in Kidney Diseases
Stem cell therapy is being explored for its regenerative potential in kidney damage.
Types of stem cells:
- Mesenchymal stem cells (MSCs): Derived from bone marrow or adipose tissue
- Renal progenitor cells
Mechanism of action:
- Anti-inflammatory and immunomodulatory effects
- Promotion of tubular cell regeneration
- Reduction of fibrosis and apoptosis
- Enhancement of microvascular repair
Applications:
- Acute kidney injury
- Diabetic nephropathy
- Chronic glomerular and interstitial diseases
Hyperbaric Oxygen Therapy (HBOT) in Kidney Diseases
HBOT delivers 100% oxygen under increased pressure to enhance tissue oxygenation and healing.
Mechanism:
- Increases oxygen supply to hypoxic renal tissues
- Reduces inflammation and oxidative stress
- Promotes angiogenesis and cellular repair
Applications:
- Renal ischemia-reperfusion injury
- Adjunctive therapy for wound healing in diabetic kidney disease
- Under investigation for prevention of contrast-induced nephropathy
Lifestyle and Supportive Management
Dietary adjustments:
- Low-sodium, kidney-friendly diets
- Fluid restrictions in advanced stages
Exercise: Moderate activity to control blood pressure and weight
Smoking cessation and alcohol moderation
Vaccinations: To reduce infection risk, especially hepatitis and flu
Mental health support: For dealing with chronic illness and dialysis
Monitoring and Follow-Up
- Regular testing of kidney function (GFR), electrolytes, and urine protein
- Blood pressure and glucose control monitoring
- Screening for complications such as cardiovascular disease
Prognosis
Prognosis depends on the underlying cause, disease stage at diagnosis, and adherence to treatment. Early intervention can slow or halt progression, while ESRD requires lifelong renal replacement therapy. Advances in regenerative therapies offer potential to restore kidney function and reduce reliance on dialysis or transplantation in the future.
Conclusion
Kidney diseases are serious conditions that require timely detection and integrated care to prevent progression and complications. While conventional treatments focus on controlling contributing factors and symptoms, emerging regenerative approaches like stem cell therapy and HBOT offer hope for repairing kidney tissue and improving outcomes. A holistic, patient-centered strategy combining medical, dietary, lifestyle, and emerging therapies is key to managing kidney diseases effectively and improving quality of life.
Working Time
- Monday-Saturday 09:00 AM TO 06:00 PM
Contact Info
-
Phone: +9175750 05090